Hao Wang

Hao Wang

Auto-generated profile, based on publicly available information

Hao Wang

Prenatal Diagnosis Center , Hangzhou Women’s Hospital , Hanghzou , China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Science Advances
Verified
Journal Article
Open access
XMXiaojie Ma
Xiaojie Ma
YLYunkun Lu
Yunkun Lu
ZZZiyu Zhou
Ziyu Zhou
QLQin Li
Qin Li
XCXi Chen
Xi Chen
SZSaiyong Zhu
Saiyong Zhu
An unlimited source of human pancreatic β cells is in high demand. Even with recent advances in pancreatic differentiation from human pluripotent stem cells, major hurdles remain in large-scale and cost-effective production of functional β cells. Here, through chemical screening, we demonstrate that the bromodomain and extraterminal domain (BET) inhibitor I-BET151 can robustly promote the expansion of PDX1 + NKX6.1 + pancreatic progenitors (PPs). These expandable PPs (ePPs) maintain pancreatic progenitor cell status in the long term and can efficiently differentiate into functional pancreatic β (ePP-β) cells. Notably, transplantation of ePP-β cells rapidly ameliorated diabetes in mice, suggesting strong potential for cell replacement therapy. Mechanistically, I-BET151 activates Notch signaling and promotes the expression of key PP-associated genes, underscoring the importance of epigenetic and transcriptional modulations for lineage-specific progenitor self-renewal. In summary, our studies achieve the long-term goal of robust expansion of PPs and represent a substantial step toward unlimited supplies of functional β cells for biomedical research and regenerative medicine.

1 September 2021 in Stem Cell Reports
Verified
Journal Article
Open access
DZDanni Zhou
Danni Zhou
YTYing Tan
Ying Tan
XLXiao-Ling Liu
Xiao-Ling Liu
LTLing Tang
Ling Tang
HWHao Wang
Hao Wang
MZMing-Hui Zhao
Ming-Hui Zhao
Atypical hemolytic uremic syndrome (aHUS) is a rare disease associated with high morbidity and mortality. Existing evidence suggests that the central pathogenesis to aHUS might be endothelial cell damage. Nevertheless, the role of endothelial cell alterations in aHUS has not been well characterized and the underlying mechanisms remain unclear. Utilizing an induced pluripotent stem cell-derived endothelial cell (iPSC-EC) model, we showed that anti-complement factor H autoantibody-associated aHUS patient-specific iPSC-ECs exhibited an intrinsic defect in endothelial functions. Stimulation using aHUS serums exacerbated endothelial dysfunctions, leading to cell apoptosis in iPSC-ECs. Importantly, we identified p38 as a novel signaling pathway contributing to endothelial dysfunctions in aHUS. These results illustrate that iPSC-ECs can be a reliable model to recapitulate EC pathological features, thus providing a unique platform for gaining mechanistic insights into EC injury in aHUS. Our findings highlight that the p38 MAPK signaling pathway can be a therapeutic target for treatment of aHUS.

16 May 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YJYan Jin
Yan Jin
YLYunkun Lu
Yunkun Lu
LLLianyu Lin
Lianyu Lin
CLChao Liu
Chao Liu
XMXiaojie Ma
Xiaojie Ma
SZSaiyong Zhu
Saiyong Zhu
Chemistry-alone approach has recently been applied for incepting pluripotency in somatic cells, representing a breakthrough in biology. However, chemical reprogramming is hampered by low efficiency, and the underlying molecular mechanisms remain unclear. Particularly, chemical compounds do not have specific DNA-recognition domains or transcription regulatory domains, and then how do small molecules work as a driving force for reinstating pluripotency in somatic cells? Furthermore, how to efficiently clear materials and structures of an old cell to prepare the rebuilding of a new one? Here, we show that small molecule CD3254 activates endogenous existing transcription factor RXRα to significantly promote mouse chemical reprogramming. Mechanistically, CD3254–RXRα axis can directly activate all the 11 RNA exosome component genes ( Exosc1–10 and Dis3 ) at transcriptional level. Unexpectedly, rather than degrading mRNAs as its substrates, RNA exosome mainly modulates the degradation of transposable element (TE)-associated RNAs, particularly MMVL30 , which is identified as a new barrier for cell-fate determination. In turn, MMVL30 -mediated inflammation (IFN-γ and TNF-α pathways) is reduced, contributing to the promotion of successful reprogramming. Collectively, our study provides conceptual advances for translating environmental cues into pluripotency inception, particularly, identifies that CD3254–RXRα–RNA exosome axis can promote chemical reprogramming, and suggests modulation of TE-mediated inflammation via CD3254-inducible RNA exosome as important opportunities for controlling cell fates and regenerative medicine.

18 May 2022 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
YYYang Yang
Yang Yang
MWMin Wang
Min Wang
HWHao Wang
Hao Wang

27 December 2019 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
YYYang Yang
Yang Yang
WHWang Hao
Wang Hao
Background: Isodicentric Y chromosomes [idic(Y)] are one of the most common structural abnormalities of the Y chromosome. The prenatal diagnosis of isodicentric Y chromosomes is of vital importance, and the postnatal phenotypes vary widely. Therefore, we present six patients prenatally diagnosed with isodicentric Y chromosomes and review the literature concerning the genotype-phenotype correlations. Method: The clinical materials of six patients were obtained. Cytogenetic and molecular approaches were carried out for these six patients. Results: Isodicentric Y chromosomes were found in all sixpatients. Among them, four patients presented with a mosaic 45,X karyotype, one patient had a 46,XY cell line, and one patient was nonmosaic. Five of these six isodicentric Y chromosomes had a breakpoint in Yq11.2, and the other had a breakpoint in Yp11.3. The molecular analysis demonstrated different duplications and deletions of the Y chromosome. Finally, three patients chose to terminate the pregnancy, two patients gave birth to normal-appearing males, and one patient was lost to follow-up. Conclusion: The incorporation of multiple cytogenetic and molecular techniques would offer a more comprehensive understanding of this structural chromosomal abnormality for genetic counselling.

10 February 2022 in Clinical Biochemistry
Verified
Journal Article
Closed access
YYYang Yang
Yang Yang
HWHao Wang
Hao Wang